Driving the future of AI in Pharma and Healthcare through innovative science and real-world insights

TRUSTED BY TECH'S ELITE

Get involved with the only AI business event powered by Industry Leaders

ABOUT

The inaugural AI Health & Pharma Summit is bringing together the key stakeholders in pharma and healthcare to transform and enhance scientific research based on better decision-making, optimized innovation, improved efficiency of clinical trials, and new tool creation for physicians, consumers, insurers, and regulators.
As part of the world’s largest AI event, The AI Summit London gathers 10,000 Expo visitors, 3,000 conference delegates, 300 speakers across 7 theatres (including dedicated technical streams for developers and engineers); it is now the flagship AI show of London Tech Week, supported by The Mayor of London and the UK Government

2018 EARLY CONFIRMED KEYNOTES

Get involved with the only AI business event powered by Industry Leaders

WHY ATTEND

Be part of the event dedicated to discussing how artificial intelligence has truly moved from concept to reality in the pharmaceutical industry

Current R&D is unstable – don’t miss out on the opportunity to hear case studies on machine learnings potential to expedite timelines, identify better drugs and de-risk development

Experience unrivalled networking our opening VIP reception for speakers & VIP delegates is hosted at Kensington Palace, a living UK Royal residence

Get the latest on technology solutions from leading providers in the field in a strictly no-sales pitch environment

Push the boundaries of discovery and development through the entire product lifecycle and benchmark with peers on how AI is shaking up the life-sciences industry

Join industry leaders as they discuss pertinent topics; from the acceleration of regulatory submissions – by identifying data gaps that have led to delays or rejections in the past – to the transformation of the conduct of clinical trials and patient safety monitoring. Artificial intelligence has substantial potential to change the way life sciences organisations operate

THE PIVOTAL MESSAGES

A typical drug can cost upwards of $2.5 billion and a decade or more to identify and test a new drug candidate.

AI will have a major impact on the speed of drug discovery, as well as cutting R&D costs –  eventually creating better medicines.

Today only about one in ten drugs that enter phase 1 clinical trials reach the patient

The breakthroughs in machine learning will change the process for pharma and will impact the whole industry tremendously

The number of start-ups in the space has increased in recent years, with deals to healthcare focussed start-ups going up year on year.

The field of AI for healthcare has been actively growing with the market is primarily being driven but factors like the rise of personalised medicine and big data in the healthcare industry.

2017 SPONSORS & PARTNERS

OFFICIAL MEDIA PARTNERS

REPORTED BY

VENUE

ExCel Exhibition Centre
Royal Victoria Dock,
1 Western Gateway,
London
E16 1XL